ZH
RU
ES

abnormal bone metabolism

abnormal bone metabolism, Total:17 items.

In the international standard classification, abnormal bone metabolism involves: Medical sciences and health care facilities in general, Road vehicles in general.

Professional Standard - Hygiene , abnormal bone metabolism

WS/T 357-2011 Clinical practice guidelines of bone metabolic markers

National Health Commission of the People's Republic of China, abnormal bone metabolism

WST 357:2011 Guidelines for clinical application of bone metabolism markers (obsolete)

The American Road & Transportation Builders Association, abnormal bone metabolism

AASHTO T 326-2005 Standard Method of Test for Uncompacted Void Content of Coarse Aggregate (As Influenced by Particle Shape, Surface Texture, and Grading)

Professional Standard - Agriculture, abnormal bone metabolism

747药典化学药和生物制品卷-2010 Chapter IX Drugs for the Endocrine System Section Eight Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (1) Bone Absorption Inhibitor Calcitonin
745药典化学药和生物制品卷-2010 Chapter IX Drugs for the Endocrine System Section Eight Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (1) Bone Absorption Inhibiting Drug Zoledronic Acid
741药典化学药和生物制品卷-2010 Chapter IX Drugs for the Endocrine System Section VIII Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (1) Bone Resorption Inhibiting Drug Clortronate Sodium
744药典化学药和生物制品卷-2010 Chapter IX Drugs for the Endocrine System Section Eight Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (1) Ibandronic Sodium Sodium Bone Resorption Inhibitor
746药典化学药和生物制品卷-2010 Chapter IX Endocrine System Medicines Section Eight Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (1) Salmon Calcitonin Inhibiting Bone Absorption Drugs
742药典化学药和生物制品卷-2010 Chapter IX Drugs for the Endocrine System Section Eight Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (1) Bone Resorption Inhibiting Drug Alendronate Sodium
740药典化学药和生物制品卷-2010 Chapter IX Drugs for the Endocrine System Section VIII Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (1) Bone Resorption Inhibiting Drug Etidronate Sodium
743药典化学药和生物制品卷-2010 Chapter IX Endocrine System Medicines Section Eight Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (1) Bone Absorption Inhibiting Drug Pamidronate Disodium
748药典化学药和生物制品卷-2010 Chapter IX Drugs for the Endocrine System Section VIII Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (1) Bone Resorption Inhibiting Drug Raloxifene Hydrochloride
750药典化学药和生物制品卷-2010 Chapter IX Drugs for the Endocrine System Section VIII Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (III) Strontium Ranelate, a Drug That Can Inhibit Bone Resorption and Promote Bone Formation
738药典化学药和生物制品卷-2010 Chapter 9 Medications for the Endocrine System Section 8 Calcium and Phosphorus Metabolism Regulating Drugs 2. Vitamin D Calcitriol
749药典化学药和生物制品卷-2010 Chapter IX Drugs for the Endocrine System Section VIII Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (2) Drugs for Promoting Bone Formation Recombinant Human Parathyroid Hormone (1-34)*
739药典化学药和生物制品卷-2010 Chapter IX Drugs for the Endocrine System Section VIII Calcium and Phosphorus Metabolism Regulating Drugs II. Vitamin D Alfacalcidol
751药典化学药和生物制品卷-2010 Chapter IX Endocrine System Drugs Section Eight Calcium and Phosphorus Metabolism Regulating Drugs III. Anti-Osteoporosis Drugs (IV) Other Drugs Ipriflavone